David W. Fryrear

David Fryrear is the senior director and global head of clinical and pharmacovigilance quality assurance at AbbVie. David leads a global team of quality assurance professionals who are responsible for the quality program management and conduct of risk-based compliance audits for regulated clinical development and pharmacovigilance activities. David has spent the much of his career developing and improving quality systems, including those supporting product development and safety. Prior to joining AbbVie, he had been at Eli Lilly for 23 years, the last 10 in leadership positions in quality assurance.